Approval · Notice of Compliance 6647 · 2005
MICARDIS: Notice of Compliance 6647
Issued May 6, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6647
- Date
- May 6, 2005
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updating the indication for the treatment of mild to moderate essential hypertension
- Therapeutic class
- Angiotensin ii at1 receptor blocker
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICARDIS | Not yet assigned | — |
Medicinal ingredients
- TELMISARTAN 40 MG per TAB
- TELMISARTAN 80 MG per TAB